We make science fit for the real world
Smart science alone does not ensure best patient outcomes. That is why our Medical division, led by ApotheCom, drives an integrated approach to medical strategy – combining science, market access, data and analytics to deliver meaningful change.
The Medical division works primarily with medical affairs stakeholders across pharmaceutical and biotechnology clients in the development and delivery of strategy and activities across the life cycle of a product. Core services span scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, payer and value communications and support for internal medical teams.
Increasingly, medical affairs is taking a strategic and lead role in bringing new products to market, particularly areas of specialised medicine and rare diseases. This is driven by increased evidence requirements; market access hurdles; proliferation of stakeholders including patients who require information about clinical studies; and the strict regulatory environment meaning that activities prior to launch are increasingly medically led.
Discover more about ApotheCom.